The International 14th Puijo Symposium:
“Physical Activity, Diet and Cardiovascular Diseases - A Fresh Look Beyond Old Facts”
Scientific Program
June 25, 1996
PREVENTION OF CARDIOVASCULAR DISEASES
Clinical Trials on Physical Exercise and CHD Risk Factors Current State of the Artó, Dr Arthur S. Leon, USA
Scientific Basis for Medical Prescription of Physical Exercise, Dr William L. Haskell, USA
Diet and Coronary Heart Disease - the Finnish Experiences, Dr Antti Aro, Finland
NEW INSIGHTS INTO PREVENTION OF CARDIOVASCULAR DISEASES
Pathophysiology and Genetics of Insulin Resistance Syndrome, Dr Markku Laakso, Finland
Epidemiology of Insulin Resistance Syndrome, Dr Markolf Hanefeld, Germany
Physical Activity, Muscular Metabolism and the Insulin Resistance Syndrome, Dr Angelo Tremblay, Canada
Visceral Obesity as a Component of the Insulin Resistance Dyslipidemic Syndrome: Effect of Physical Activity, Dr Claude Bouchard, Canada
Early Intervention in NIDDM and Impaired Glucose Tolerance, Dr Matti Uusitupa, Finland
June 26, 1996
LIPOPROTEIN METABOLISM AND ATHEROGENESIS
Gender Differences in Coronary Heart Disease: Why Are Women So Superior? Dr Elizabeth Barrett-Connor, USA
LDL-Particle Size in Atherogenesis, Dr Manfred Baumstark, Germany
Lessons from HDL-Deficiency for Reverse Cholesterol Transport, Dr Arnold von Eckardstein, Germany
Lipoprotein(a) and Atherogenesis, Dr Christian Enholm, Finland
Molecular Mechanisms of Reverse Cholesterol Transport, Dr Matti Jauhiainen, Finland
Remnants, apoE and atherosclerosis, Dr Jean Davignon, Canada
Physical Activity and Lipoprotein Metabolism: Epidemiological Evidence and Clinical Trials, Dr Aloys Berg, Germany
Diet and Lipoprotein Metabolism: Epidemiological Evidence and Clinical Trials, Dr Antero Kesäniemi, Finland
Future Directions in Research: Physical Activity, Diet and Lipoprotein Metabolism, Dr Steven N. Blair, USA
June 27, 1996
THROMBOGENESIS IN CARDIOVASCURAL DISEASES
Role of Thrombosis and Fibrinolysis in CHD, Dr Tom Meade, UK
Physical Activity and Thrombogenesis: Epidemiological Observations and Clinical Trials, Dr Tuomo Rankinen, Finland
Diet and Thrombogenesis: Epidemiological Observations and Clinical Trials, Dr George Miller, UK
Gene-Environment Interaction in the Determination of Plasma Levels of Fibrinogen and Factor V, Dr Fiona Green, UK
Gene-Environment Interactions Determining Fibrinolytic Function, Dr Anders Hamsten, Sweden
Future Directions in Research: Physical Activity and Thrombogenesis, Dr Rainer Rauramaa, Finland
June 28, 1996
MOLECULAR BIOLOGY
Gene Therapy for Atherosclerosis, Dr Marja Laitinen, Finland
Gene-Physical Activity and Gene-Diet Interactions: from Genetic Epidemiology to Molecular Markers, Dr Claude Bouchard, Canada
Fit for Life – National Health Program in Finland, Dr Timo Haukilahti, Finland